Medium-term results of neoadjuvant systemic chemotherapy using irinotecan, 5-fluorouracil, and leucovorin in patients with locally advanced rectal cancer

European Journal of Surgical Oncology

Volumn 36, Issue 11, 2010, Pages 1061-1065

  Ishii, Y ^a   Hasegawa, H ^a   Endo, T ^a   Okabayashi, K ^a   Ochiai, H ^b   Moritani, K ^a   Watanabe, M ^c   Kitagawa, Y ^a  

^a KEIO UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

5 Fluorouracil; Irinotecan; Leucovorin; Medium term results; Neoadjuvant systemic chemotherapy; Rectal cancer

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANOREXIA NERVOSA; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE FREE SURVIVAL; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECTUM CANCER; THROMBOCYTOPENIA; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; DRUG ADMINISTRATION; MIDDLE AGED; PATHOLOGY; PROCEDURES; RECTAL NEOPLASMS; TIME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CHEMOTHERAPY, ADJUVANT; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; RECTAL NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77957880951     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2010.05.017     Document Type: Article

References (37)

1. R.J. Heald, and R.D. Ryall Recurrence and survival after total mesorectal excision for rectal cancer Lancet 1 1986 1479 1482
2. J.K. MacFarlane, R.D. Ryall, and R.J. Heald Mesorectal excision for rectal cancer Lancet 341 1993 457 460
3. Colorectal Cancer Collaborative Group Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials Lancet 358 2001 1291 1304
4. E. Kapiteijn, C.A. Marijnen, I.D. Nagtegaal Dutch Colorectal Cancer Group Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med 345 2001 638 646
5. Swedish Rectal Cancer Trial Improved survival with preoperative radiotherapy in resectable rectal cancer N Engl J Med 336 1997 980 987
6. K.C. Peeters, C.A. Marijnen, I.D. Nagtegaal Dutch Colorectal Cancer Group The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma Ann Surg 246 2007 693 701
7. T. Holm, T. Singnomklao, L.E. Rutqvist, and B. Cedermark Adjuvant preoperative radiotherapy in patients with rectal carcinoma. Adverse effects during long term follow-up of two randomized trials Cancer 78 1996 968 976
8. M. Dahlberg, B. Glimelius, W. Graf, and L. Phlman Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study Dis Colon Rectum 41 1998 543 549
9. H. Birgisson, L. Phlman, U. Gunnarsson, B. Cedermark, B. Glimelius, and U. Gunnarsson Swedish rectal cancer trial group:adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish rectal cancer trial J Clin Oncol 23 2005 8697 8705
10. S. Fujita, S. Yamamoto, T. Akasu, and Y. Moriya Lateral pelvic lymph node dissection for advanced lower rectal cancer Br J Surg 90 2003 1580 1585
11. M. Kusters, G.L. Beets, and C.J. van de Velde A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence Ann Surg 249 2009 229 235
12. E. Van Cutsem, F. Rivera, and S. Berry on behalf of the First BEAT investigators: Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study Ann Oncol 20 2009 1842 1847
13. E. Van Cutsem, C.H. Köhne, and E. Hitre Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer N Engl J Med 360 2009 1408 1417
14. J. Tol, M. Koopman, and A. Cats Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer N Engl J Med 360 2009 563 572
15. H. Hurwitz, L. Fehrenbacher, and W. Novotny Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2004 2335 2342
16. L.B. Saltz, J.V. Cox, and C. Blanke Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group N Engl J Med 343 2000 905 914
17. H. Hasegawa, M. Watanabe, and H. Baba Neoadjuvant chemotherapy of irinotecan, 5-fluorouracil and leucovorin in patients with advanced rectal cancer. Report of two cases Hepatogastroenterology 49 2002 891 893
18. G. Theodoropoulos, W.E. Wise, and A. Padmanabhan T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival Dis Colon Rectum 45 2002 895 903
19. L. Ruo, S. Tickoo, and D.S. Klimstra Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy Ann Surg 236 2002 75 81
20. J. García-Aguilar, E. Hernandez de Anda, P. Sirivongs, S.H. Lee, R.D. Madoff, and D.A. Rothenberger A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision Dis Colon Rectum 46 2003 298 304
21. C.L. Brown, C.A. Ternent, and A.G. Thorson Response to preoperative chemoradiation in stage II and III rectal cancer Dis Colon Rectum 46 2003 1189 1193
22. C.H. Crane, C. Eng, and B.W. Feig Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer Int J Radiat Oncol Biol Phys 76 2010 824 830
23. T. Sato, Y. Kokuba, and W. Koizumi Irinotecan and S-1 neoadjuvant chemoradiation therapy in patients with advanced rectal cancer Hepatogastroenterology 54 2007 1391 1393
24. R. Glynne-Jones, S. Falk, T.S. Maughan, H.M. Meadows, and D. Sebag-Montefiore A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a colorectal clinical oncology group study Br J Cancer 96 2007 551 558
25. M.G. Fakih, K. Bullarddunn, and G.Y. Yang Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma Int J Radiat Oncol Biol Phys 72 2008 650 657
26. D. Koeberle, R. Burkhard, and R. von Moos Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer Br J Cancer 98 2008 1204 1209
27. D.P. Ryan, D. Niedzwiecki, and D. Hollis Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901 J Clin Oncol 24 2006 2557 2562
28. F. Willeke, K. Horisberger, and U. Kraus-Tiefenbacher A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer Br J Cancer 96 2007 912 917
29. M. Mohiuddin, K. Winter, and E. Mitchell Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012 J Clin Oncol 24 2006 650 655
30. G. Klautke, P. Feyerherd, K. Ludwig, F. Prall, T. Foitzik, and R. Fietkau Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer Br J Cancer 92 2005 1215 1220
31. J.F. Bosset, L. Collette, G. Calais EORTC Radiotherapy Group Trial 22921 chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 2006 1114 1123
32. J.P. Gérard, T. Conroy, and F. Bonnetain Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203 J Clin Oncol 24 2006 4620 4625
33. K. Bujko, M.P. Nowacki, A. Nasierowska-Guttmejer, W. Michalski, M. Bebenek, and M. Kryj Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer Br J Surg 93 2006 1215 1223
34. M.S. Roh, L.H. Colangelo, and M.J. O'Connell Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03 J Clin Oncol 27 2009 5124 5130
35. R. Sauer, H. Becker, W. Hohenberger German Rectal Cancer Study Group Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
36. H. Kobayashi, H. Mochizuki, and T. Kato Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection Dis Colon Rectum 52 2009 567 576
37. J.C. Kim, K. Takahashi, and C.S. Yu Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer Ann Surg 246 2007 754 762